Glanzmann Thrombasthenia
📧 Sign up to get email alerts when something new happens for Glanzmann Thrombasthenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: ATHNdataset Registry
The ATHNdataset Registry is currently recruiting participants; sponsored by the American Thrombosis and Hemostasis Network, the registry cov…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of HMB-001 in Glanzmann thromba…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531) [Phase 2]
A Phase 2 trial evaluating Eptacog Beta for Glanzmann thrombasthenia is currently recruiting, sponsored by Emory University.
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.
A clinical trial update from Rockefeller University exploring the genetics and functional basis of inherited blood disorders, including Glan…
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: Clinical Pattern of Glanzemnn Thrombathenia in Children Attending Assiut University Children Hospital
A clinical trial at Assiut University Children's Hospital is studying the clinical pattern of Glanzmann thrombasthenia in children; the stud…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.